An interventional study of Empowered Relief in Chronic Pain, Cesarean Section Complications and Postpartum, sponsored by Stanford University. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
This pilot study will evaluate the feasibility and acceptability of delivering Empowered Relief (ER), a single-session pain relief skills class, to postpartum women with ongoing pain and/or pain interference following cesarean delivery. Participants will receive ER in addition to standard postpartum care and will be followed through 12 weeks postpartum.
3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Browse Chronic Pain studies →Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a single 120-minute Empowered Relief session in addition to standard postpartum care. The session includes pain education and cognitive-behavioral pain management skills, including relaxation, deep breathing, reframing, and development of a personalized plan. Participants will also receive access to a smartphone relaxation resource (Calm Tool app, or a relaxation audio file if the app cannot be downloaded).
Behavioral: Empowered Relief
A single 120-minute pain relief skills class delivered by trained, certified instructors via Zoom or in person. The session includes pain education, cognitive behavioral skills including relaxation, deep breathing, and reframing, and completion of a personalized plan. Following the session, participants receive access to the Calm Tool smartphone relaxation app (or a binaural relaxation audio file if the app cannot be downloaded).
Proportion of enrolled patients that complete the Empowered Relief session
The proportion of enrolled patients that complete the single 120-minute Empowered Relief session.
Time frame: Within 2 weeks of enrollment
Proportion of screened patients who are eligible for the study
The proportion of screened patients that meet the study eligibility criteria.
Time frame: During screening, at approximately 6 weeks postpartum
Proportion of eligible patients that consent to study from those approached
The proportion of eligible patients who provide informed consent and enroll in the study.
Time frame: During screening and enrollment, at approximately 6 weeks postpartum
Proportion of recruited patients who register for the Empowered Relief session
The proportion of recruited patients who register for the Empowered Relief session.
Time frame: Within 1 week of enrollment
Proportion of recruited patients who attend the Empowered Relief session
The proportion of recruited patients who attend an Empowered Relief session.
Time frame: Within 2 weeks of baseline
Treatment Appraisal score
Treatment satisfaction assessed using the 7-item treatment appraisal questionnaire. Range 0-42, higher = greater satisfaction with the intervention
Time frame: Immediately after the Empowered Relief session, up to 2 weeks post-treatment
Qualitative feedback regarding the Empowered Relief intervention
Participant feedback regarding the Empowered Relief intervention, provided through optional free-text responses included in the Treatment Appraisal Questionnaire.
Time frame: Immediately after the Empowered Relief session, up to 2 weeks post-treatment
Participant Treatment Skills Use Scale score
Use of skills learned during the Empowered Relief intervention assessed using the 5-item Participant Treatment Skills Use Scale. Total scores range from 0 to 25, with higher scores indicating greater use of treatment skills.
Time frame: Weekly from completion of the Empowered Relief session through 12 weeks postpartum
Adherence to Study Procedures: completion rate of scheduled surveys
The percentage of scheduled study surveys completed by enrolled participants.
Time frame: From baseline at approximately 6 weeks postpartum through end-of-study at approximately 12 weeks postpartum
Adherence to study procedures: completion rate of scheduled PEG assessments
The percentage of scheduled Pain, Enjoyment, General Activity (PEG) assessments completed by enrolled participants.
Time frame: From baseline at approximately 6 weeks postpartum through end-of-study at approximately 12 weeks postpartum
Adherence to study procedures: proportion of participants retained through end-of-study follow-up
The proportion of enrolled participants who remain in the study through the end-of-study follow-up assessment.
Time frame: From baseline at approximately 6 weeks postpartum through end-of-study at approximately 12 weeks postpartum
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.